glp-1 diabetes news A wave of new #GLP1 drug options for type 2 #Diabetes and #Obesity was a major focus at #ADA2026. In the latest JAMA Medical podcast, Jennifer Abbasi interviews Rita Kalyani, MD New research identifies a mechanism

A comparative atlas of single-cell chromatin accessibility in the human brain

Effects typically last 6 to 12 hours , with some reporting longer-lasting changes in desire up to 72 hours

Some papers found effects (Parmley et al

Market-Based Data Collection In order to support the development of a relative market-based payment methodology under the IPPS, we proposed to collect market-based payment rate data on the Medicare cost report for cost reporting periods ending on or after January 1, 2026

Can I take a low dose just for glow

In contrast, studies on the currently available oral semaglutide tablets show more modest results